Patients with liver cirrhosis and, in particular, those with liver failure are at high risk of
reduced muscle mass and strength/function, otherwise known as sarcopenia. Sarcopenia is …

Background Sarcopenia (loss of muscle mass) is common in cirrhosis and is associated with
poor outcomes. Current teaching recommends the use of protein supplementation and …

Sarcopenia (severe muscle depletion) is a prevalent muscle abnormality in patients with
cirrhosis that confers poor prognosis both pre-and post-liver transplantation. The …

Introduction: Sarcopenia is defined as loss of skeletal muscle mass, strength, and function,
and it is associated with increased morbidity and mortality in patients with chronic liver …

Sarcopenia, defined as loss of muscle mass and function, is increasingly recognized as a
common consequence of advanced cirrhosis that is associated with adverse clinical …

Sarcopenia is a common complication of cirrhosis and is defined as a progressive and
generalized loss of skeletal muscle mass, strength, and function. Sarcopenia is associated …

As the cirrhosis progresses, development of complication like ascites, hepatic
encephalopathy, variceal bleeding, kidney dysfunction, and hepatocellular carcinoma …

Cirrhosis is the consequence of progression of many forms of necro-inflammatory disorders
of the liver with hepatic fibrosis, hepatocellular dysfunction, and vascular remodeling …

In patients with decompensated cirrhosis, sarcopenia and frailty are prevalent. Although
several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly …

The most commonly recognized complications in cirrhotic patients include ascites, hepatic
encephalopathy, variceal bleeding, susceptibility for infections, kidney dysfunction, and …